1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane has been researched along with propamidine in 4 studies
| Studies (1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane) | Trials (1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane) | Recent Studies (post-2010) (1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane) | Studies (propamidine) | Trials (propamidine) | Recent Studies (post-2010) (propamidine) |
|---|---|---|---|---|---|
| 27 | 10 | 21 | 93 | 0 | 20 |
| Protein | Taxonomy | 1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane (IC50) | propamidine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 5.54 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 5.54 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.54 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.54 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.54 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.54 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.54 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiconi, G; Bolognesi, M; Bortolotti, F; Coletta, M; Ferroni, R; Fruttero, R; Menegatti, E; Nastruzzi, C; Onesti, S; Scalia, S | 1 |
| Binato, G; Feriotto, G; Ferroni, R; Gambari, R; Manfredini, S; Nastruzzi, C; Orlandini, P; Simoni, D | 1 |
| Cortesi, R; Feriotto, G; Gambari, R; Nastruzzi, C | 1 |
| Bianchi, N; Borgatti, M; Breda, L; Feriotto, G; Gambari, R; Jeang, KT; Mischiati, C | 1 |
4 other study(ies) available for 1,3-bis(4-amidinophenoxy)-2-(4-amidinophenoxymethyl)ethylpropane and propamidine
| Article | Year |
|---|---|
Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Topics: Animals; Benzamidines; Cattle; Humans; Hydrogen-Ion Concentration; Kallikreins; Magnetic Resonance Spectroscopy; Models, Molecular; Pancreas; Serine Proteinase Inhibitors; Swine; Thermodynamics; Thrombin; Trypsin Inhibitors; X-Ray Diffraction | 1991 |
N1-substituted benzamidines: synthesis, antiproteinase activity and inhibition of tumor cell growth.
Topics: Animals; Antineoplastic Agents; Benzamidines; Cattle; Cell Division; Humans; Kallikreins; Magnetic Resonance Spectroscopy; Protease Inhibitors; Spectrophotometry, Infrared; Structure-Activity Relationship; Trypsin Inhibitors; Tumor Cells, Cultured | 1991 |
Effects of aromatic polyamidines on the electrophoretic mobility of HIV-1 genomic regions amplified by polymerase-chain reaction.
Topics: Base Sequence; Benzamidines; DNA, Viral; Electrophoresis, Agar Gel; Gene Amplification; Genome, Viral; HIV Long Terminal Repeat; HIV-1; Molecular Sequence Data; Polymerase Chain Reaction | 1991 |
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
Topics: Anti-HIV Agents; Benzamidines; Cell Line; Drug Design; Electrophoretic Mobility Shift Assay; Gene Expression Regulation, Viral; Gene Products, tat; HIV Long Terminal Repeat; HIV-1; Humans; Jurkat Cells; Nucleic Acid Conformation; RNA, Viral; Structure-Activity Relationship; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation | 2001 |